Did the abuse of non-opioid substances in combination with non-prescription fentanyl increase or decrease during the first 2 months of the COVID pandemic shutdown compared to earlier in 2020 and in 2019?
Abuse of non-opioid substances in combination with non-prescription fentanyl increased dramatically during the first two months of the COVID pandemic. For example, the use of non-prescription fentanyl: with amphetamines increased by 89% (P<0.01) , with benzodiazepines increased by 48% (P<0.01) , with cocaine increased by 34% (P<0.01)
Did abuse of non-prescription fentanyl increase or decrease during the first 2 months of the COVID pandemic shutdown compared to earlier in 2020 and in 2019?
According to an analysis of Quest Diagnostics data, non-prescription fentanyl abuse increased by 35% during the time period of March 15 to May 16, 2020 (P<0.01). Among males, the percentage of those positive for opioid use increased from 5.7% to 8.6%, while the rate for females increased from 3.2% to 3.7%. The positivity rate increased for all age groups. Of note, there was an increase from 10.2% to 13.4% for the 18 to 24 years old, age group.
What are some of the more common reasons dermatologists recommend cannabinoid-based medicines?
According to the results of a survey of 145 dermatologists, 91 % of dermatologists were in support of medical cannabis use and 13.8 % have recommended it for a dermatologic condition. Atopic dermatitis (45 %) and psoriasis (40 %) were the most common. The most common form of administration was topical (75 %). The main reasons for not recommending medical cannabis were limited knowledge (56 %) and lack of experience (48 %).